MedTrace Logo

AVEIR DR Coverage With Evidence Development (CED) Study

NCT05932602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2812

Last updated 2025-04-06

No results posted yet for this study

Summary

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).

Conditions

  • Cardiac Pacemaker
  • Arrythmia
  • Bradycardia

Interventions

DEVICE

Aveir DR Leadless Pacemaker System

This study will utilize real-world data from patients implanted with the Aveir DR Leadless Pacemaker System. No device intervention is required in this study.

DEVICE

Dual Chamber Transvenous Pacemaker

This study will utilize real-world data from patients implanted with a dual-chamber transvenous pacemaker as a comparator to the Aveir DR LP system study arm. No device intervention is required in this study.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Nicole Harbert · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2029-05-31
Completion
2030-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932602 on ClinicalTrials.gov